Bonus season is fast approaching, and Biglaw associates across the country are watching closely to see what their firms will deliver this year. For many associates working through the fall of 2026,
Mark Herrmann, a former partner at a leading international law firm, has had enough of certain recurring figures in American public life. At the top of his list is Michael Cohen, Donald
More
Teva Pharmaceutical Industries (TEVA) has begun trading its ordinary shares directly on the New York Stock Exchange, marking a significant milestone for the global drugmaker. The move represents a key step in
More
Trainline PLC, the UK-listed online rail and coach ticketing platform, has seen its shares attract renewed investor interest following a positive period for the FTSE 250 index. The FTSE 250, which tracks
More
London has secured second place in a ranking of 1,000 global destinations, but its housing affordability crisis is significantly undermining its overall appeal to workers and residents. The latest Global Cities Index
More
The Organisation for Economic Co-operation and Development has published a new guidance document addressing toxicokinetics testing specifically designed to accommodate the study of (nano)particles. Posted on August 10, 2026, the document provides
More
The United States Supreme Court, one of the most powerful institutions in the world, spent the majority of its early history without a permanent home of its own. Before securing a dedicated
More
Chevron (NYSE: CVX) remains one of the most closely watched names in the diversified upstream exploration and production sector heading into mid-2026. The company operates across a broad range of geographies, giving
More
Business leaders are pressing Chancellor John Healey to reverse inheritance tax reforms they say are actively damaging family-run companies across the United Kingdom. A coalition of top industry bodies, representing more than
More
Scholar Rock has secured FDA approval for Isembyld (apitegromab-mstn), a first-of-its-kind treatment targeting muscle loss in spinal muscular atrophy patients. The approval covers adults and paediatric patients aged two years and older
More
In a significant ruling for digital privacy law, a federal court has denied Smith & Wesson’s motion to dismiss a California Invasion of Privacy Act lawsuit over website tracking. The case, D’Antonio
More